Interesting what happened with share price back in May 2019 when they announced "First Patients Complete Nerve Regeneration Trial", share price jumped from 11 cents on 29/04/2019 to 42 cents on 6/05/2019. Australian Super became a substantial holder on 14/05/2019 with a share price of around 49 cents at that time. What are people thoughts on repeating this massive share price jump (4.5x times)? Will a partnership with J&J (if it happens) be the catalyst for such a massive re-rate? Is there anything else that might attract institutional investors to invest in OCC?
Interesting what happened with share price back in May 2019 when...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $75.35M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 35.5¢ | $57.4K | 161.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 142866 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 27779 | 1 |
View Market Depth
| Last trade - 12.37pm 08/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |